Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2021 How Should a Physician Respond to Discovering Her Patient Has Been Forcibly Sterilized? Rebecca Kluchin, PhD Sterilization requires physicians’ surgical skills. Forced sterilization requires many clinicians’ complicity. AMA J Ethics. 2021;23(1):E18-25. doi: 10.1001/amajethics.2021.18. Original Research Mar 2018 Structural Competency and Reproductive Health Margaret Mary Downey, MSW and Anu Manchikanti Gómez, MSc, PhD Structural competency helps physicians address reproductive health disparities through recognizing social determinants of health and social advocacy. AMA J Ethics. 2018;20(3):211-223. doi: 10.1001/journalofethics.2018.20.3.peer1-1803. Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404.
Case and Commentary Jan 2021 How Should a Physician Respond to Discovering Her Patient Has Been Forcibly Sterilized? Rebecca Kluchin, PhD Sterilization requires physicians’ surgical skills. Forced sterilization requires many clinicians’ complicity. AMA J Ethics. 2021;23(1):E18-25. doi: 10.1001/amajethics.2021.18.
Original Research Mar 2018 Structural Competency and Reproductive Health Margaret Mary Downey, MSW and Anu Manchikanti Gómez, MSc, PhD Structural competency helps physicians address reproductive health disparities through recognizing social determinants of health and social advocacy. AMA J Ethics. 2018;20(3):211-223. doi: 10.1001/journalofethics.2018.20.3.peer1-1803.
Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404.